Jupiplatin 50 Injection
Marketer
Jupiter Formulations Private Limited
Salt Composition
Oxaliplatin (2mg/ml)
Overview Jupiplatin 50 Injection
Colonic and rectal cancers are treated with the injectable medication, Jupiplatin 50. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administration is intravenous, solely by a trained healthcare professional. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under medical supervision. Typical side effects include nausea, tiredness, vomiting, and diarrhea. This medication can lower blood cell counts (red and white), raising infection risk. Severe allergic reactions, such as mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitor blood cell levels, along with heart, liver, and uric acid function. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting drugs. Interactions with other medications are possible; inform your healthcare provider of all your current medications. This drug is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm banking should be discussed with your doctor beforehand. Post-administration dizziness may impair driving ability.
Uses of Jupiplatin 50 Injection
Colorectal cancer
Major Benefits of Jupiplatin 50 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Jupiplatin 50 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Jupiplatin 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Jupiplatin 50 Injection works:
Jupiplatin 50 Injection is a cytotoxic drug used in cancer treatment. Its mechanism of action involves disrupting the DNA and RNA of malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while receiving Jupiplatin 50 Injection is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Jupiplatin 50 Injection to pregnant individuals poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justified if potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Jupiplatin 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Jupiplatin 50 Injection or Oxaliplatin may induce adverse reactions, including dizziness, nausea, vomiting, and other neurological effects impacting gait. These reactions could impair driving ability.
KidneyCAUTION
Caution is advised when administering Jupiplatin 50 Injection to individuals with severe renal impairment; dosage modification may be necessary. Patients should seek medical advice. Data regarding Jupiplatin 50 Injection use in such patients is limited. Dosage alterations are not suggested for those with mild to moderate kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should receive Jupiplatin 50 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Jupiplatin 50 Injection :
Should you forget a Jupiplatin 50 Injection dose, seek your physician's advice.
Facts to Know About Jupiplatin 50 Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-based Anticancer Agents |
3,018 People bought this recently